ICICI Direct has buy call on Caplin Point Laboratories with a target price of Rs 540. The current market price of is Rs 507.95.
Caplin Point Laboratories Ltd., incorporated in the year 1990, is a Small Cap company (having a market cap of Rs 3835.09 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 280.21 Crore, up 3.83 % from last quarter Total Income of Rs 269.88 Crore and up 17.46 % from last year same quarter Total Income of Rs 238.55 Crore. Company reported net profit after tax of Rs 66.14 Crore in latest quarter.
Investment Rationale
The daily 14 periods RSI is in up trend and is seen rebounding taking support at its nine periods average thus validates positive bias in the stock
